| Identification | Back Directory | [Name]
BYAKANGELICIN | [CAS]
482-25-7 | [Synonyms]
Byacangelicin
Biacangelicin
Bjacangelicin
Bjakangelicin
Byankagelicine
BYAKANGELICIN(b)
BYAKANGELICIN (P)
Byakangelicin, 98%, from Ruta graveolens L.
5-Methoxy-8-(2,3-dihydroxy-3-methylbutoxy)psoralene
9-(2,3-dihydroxy-3-Methylbutoxy)-4-Methoxy-7H-furo[3,2-g]chroMen-7-one
9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxyfuro[3,2-g]chromen-7-one
9-[(2R)-2,3-dihydroxy-3-methyl-butoxy]-4-methoxy-furo[3,2-g]chromen-7-one
7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxy- | [Molecular Formula]
C17H18O7 | [MDL Number]
MFCD00468051 | [MOL File]
482-25-7.mol | [Molecular Weight]
334.32 |
| Chemical Properties | Back Directory | [Melting point ]
123-124℃ | [Boiling point ]
571.5±50.0 °C(Predicted) | [density ]
1.373 | [storage temp. ]
Sealed in dry,Store in freezer, under -20°C | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
neat | [pka]
13.67±0.20(Predicted) | [color ]
Off-White to Light Yellow |
| Hazard Information | Back Directory | [Uses]
(+)-Byakangelicin is an effective inhibitor of sex hormones and affects the catabolism of endogenous hormones. It directly affects the cytochrome P450 isoform (CY) P3A4 in human hepatocytes. Also, an inhibitor of aldose reductase and used in the treatment of diabetic cataract. | [Definition]
ChEBI: Byakangelicin is a member of psoralens. |
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|